Recall Stifles J&J's Consumer Product Sales Growth

A recall of Motrin, Tylenol and other OTC products linked to contaminated shipping pallets dashed Johnson & Johnson's expectations for launches and line extensions to drive consumer business sales growth in its most recent quarter

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet